{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T18:54:44Z","timestamp":1789412084694,"version":"build-2803163510"},"reference-count":101,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T00:00:00Z","timestamp":1692921600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Systemic sclerosis (SSc) is a connective tissue disease with an unknown etiology. Clinically, it is characterized by localized or diffuse skin thickening and fibrosis. The pathogenesis of SSc includes microvascular injury, autoimmune-mediated inflammation, and fibroblast activation. These processes interact and contribute to the diverse clinicopathology and presentation of SSc. Given the limited effectiveness and substantial side effects of traditional treatments, the treatment strategy for SSc has several disadvantages. Mesenchymal stem cells (MSCs) are expected to serve as effective treatment options owing to their significant immunomodulatory, antifibrotic, and pro-angiogenic effects. Exosomes, secreted by MSCs via paracrine signaling, mirror the effect of MSCs as well as offer the benefit of targeted delivery, minimal immunogenicity, robust reparability, good safety and stability, and easy storage and transport. This enables them to circumvent the limitations of the MSCs. When using exosomes, it is crucial to consider preparation methods, quality standards, and suitable drug delivery systems, among other technical issues. Therefore, this review aims to summarize the latest research progress on MSCs and exosomes in SSc, offering novel ideas for treating SSc.<\/jats:p>","DOI":"10.3389\/fphar.2023.1263839","type":"journal-article","created":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T11:40:28Z","timestamp":1692963628000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Research progress on mesenchymal stem cells and their exosomes in systemic sclerosis"],"prefix":"10.3389","volume":"14","author":[{"given":"Yan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/ar2186","article-title":"How does endothelial cell injury start? The role of endothelin in systemic sclerosis","volume":"9","author":"Abraham","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"B2","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.it.2005.09.004","article-title":"Scleroderma: from cell and molecular mechanisms to disease models","volume":"26","author":"Abraham","year":"2005","journal-title":"Trends Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1002\/art.21952","article-title":"Induction of apoptosis and fibrillin 1 expression in human dermal endothelial cells by scleroderma sera containing anti-endothelial cell antibodies","volume":"54","author":"Ahmed","year":"2006","journal-title":"Arthritis Rheum."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/s41409-022-01702-w","article-title":"Hematopoietic stem cell transplantation and cellular therapies for autoimmune diseases: overview and future considerations from the autoimmune diseases working party (ADWP) of the European society for blood and marrow transplantation (EBMT)","volume":"57","author":"Alexander","year":"2022","journal-title":"Bone Marrow Transpl."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1136\/annrheumdis-2020-218447","article-title":"A randomised, double-blind, placebo-controlled, 24-week, phase II, proof-of-concept study of romilkimab (SAR156597) in early diffuse cutaneous systemic sclerosis","volume":"79","author":"Allanore","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"6901286","DOI":"10.1155\/2016\/6901286","article-title":"Umbilical cord as prospective source for mesenchymal stem cell-based therapy","volume":"2016","author":"Arutyunyan","year":"2016","journal-title":"Stem Cells Int."},{"key":"B7","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00281-015-0505-5","article-title":"Vasculopathy in scleroderma","volume":"37","author":"Asano","year":"2015","journal-title":"Semin. Immunopathol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e0193565","DOI":"10.1371\/journal.pone.0193565","article-title":"IL-13 receptors as possible therapeutic targets in diffuse intrinsic pontine glioma","volume":"13","author":"Berlow","year":"2018","journal-title":"PLoS One"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1084\/jem.192.11.1545","article-title":"Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production","volume":"192","author":"Breitfeld","year":"2000","journal-title":"J. Exp. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"R151","DOI":"10.1186\/ar4334","article-title":"Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts: differential effects in healthy and systemic sclerosis fibroblasts","volume":"15","author":"Brembilla","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.5966\/sctm.2015-0337","article-title":"Hepatocyte growth factor is required for mesenchymal stromal cell protection against bleomycin-induced pulmonary fibrosis","volume":"5","author":"Cahill","year":"2016","journal-title":"Stem Cells Transl. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1002\/sctm.17-0051","article-title":"Mesenchymal stem cells: time to change the name","volume":"6","author":"Caplan","year":"2017","journal-title":"Stem Cells Transl. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/ar3167","article-title":"The cytokine language of monocytes and macrophages in systemic sclerosis","volume":"12","author":"Christmann","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"B14","doi-asserted-by":"publisher","first-page":"6646","DOI":"10.7150\/thno.33741","article-title":"Reversal of bleomycin-induced rat pulmonary fibrosis by a xenograft of human umbilical mesenchymal stem cells from Wharton's jelly","volume":"9","author":"Chu","year":"2019","journal-title":"Theranostics"},{"key":"B15","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.autrev.2011.04.016","article-title":"Cellular players in angiogenesis during the course of systemic sclerosis","volume":"10","author":"Cipriani","year":"2011","journal-title":"Autoimmun. Rev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s13075-015-0819-7","article-title":"Update on mesenchymal stem cell-based therapy in lupus and scleroderma","volume":"17","author":"Cras","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00109-019-01776-y","article-title":"Current understanding of the immunosuppressive properties of mesenchymal stromal cells","volume":"97","author":"de Castro","year":"2019","journal-title":"J. Mol. Med. Berl."},{"key":"B18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.berh.2004.03.001","article-title":"Scleroderma-clinical and pathological advances","volume":"18","author":"Denton","year":"2004","journal-title":"Best. Pract. Res. Clin. Rheumatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3727\/096368910X","article-title":"Mesenchymal stem cells","volume":"20","author":"Ding","year":"2011","journal-title":"Cell Transpl."},{"key":"B20","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"B21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jid.2019.05.026","article-title":"IL-17A dissociates inflammation from fibrogenesis in systemic sclerosis","volume":"140","author":"Dufour","year":"2020","journal-title":"J. Invest. Dermatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1002\/art.40016","article-title":"Scleroderma peripheral B lymphocytes secrete interleukin-6 and transforming growth factor beta and activate fibroblasts","volume":"69","author":"Dumoitier","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e267","DOI":"10.1016\/j.lpm.2014.08.001","article-title":"Pathophysiology of systemic sclerosis: state of the art in 2014","volume":"43","author":"Dumoitier","year":"2014","journal-title":"Presse Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nrgastro.2016.99","article-title":"Current management of the gastrointestinal complications of systemic sclerosis","volume":"13","author":"Emmanuel","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s12016-017-8625-4","article-title":"Cutaneous manifestations of scleroderma and scleroderma-like disorders: a comprehensive review","volume":"53","author":"Ferreli","year":"2017","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.autrev.2017.10.015","article-title":"Altered B lymphocyte homeostasis and functions in systemic sclerosis","volume":"17","author":"Fforestier","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"B27","doi-asserted-by":"publisher","first-page":"R168","DOI":"10.1186\/ar4352","article-title":"B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis","volume":"15","author":"Francois","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"B28","first-page":"267","article-title":"Fibroblast precursors in normal and irradiated mouse hematopoietic organs","volume":"4","author":"Friedenstein","year":"1976","journal-title":"Exp. Hematol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/intimm\/dxab034","article-title":"Novel insights into the pathogenesis of lung fibrosis: the RBM7-NEAT1-CXCL12-SatM axis at fibrosis onset","volume":"33","author":"Fukushima","year":"2021","journal-title":"Int. Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00441-022-03716-8","article-title":"Mesenchymal stem cells suppressed skin and lung inflammation and fibrosis in topoisomerase I-induced systemic sclerosis associated with lung disease mouse model","volume":"391","author":"Ganesan","year":"2023","journal-title":"Cell Tissue Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"650","DOI":"10.7326\/0003-4819-153-10-201011160-00007","article-title":"Autologous mesenchymal stem cells foster revascularization of ischemic limbs in systemic sclerosis: a case report","volume":"153","author":"Guiducci","year":"2010","journal-title":"Ann. Intern. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s11926-011-0217-3","article-title":"Gastrointestinal manifestations of scleroderma: recent progress in evaluation, pathogenesis, and management","volume":"14","author":"Gyger","year":"2012","journal-title":"Curr. Rheumatol. Rep."},{"key":"B33","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/biof.1587","article-title":"The role of Interleukin 1 receptor antagonist in mesenchymal stem cell-based tissue repair and regeneration","volume":"46","author":"Harrell","year":"2020","journal-title":"Biofactors"},{"key":"B34","doi-asserted-by":"publisher","first-page":"117290","DOI":"10.1016\/j.lfs.2020.117290","article-title":"Human amniotic mesenchymal stem cells alleviate paraquat-induced pulmonary fibrosis in rats by inhibiting the inflammatory response","volume":"243","author":"He","year":"2020","journal-title":"Life Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"5203","DOI":"10.3390\/ijms21155203","article-title":"The roles of immune cells in the pathogenesis of fibrosis","volume":"21","author":"Huang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"104063","DOI":"10.1016\/j.lpm.2021.104063","article-title":"Scleroderma renal crisis","volume":"50","author":"Hudson","year":"2021","journal-title":"Presse Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"530","DOI":"10.12968\/hmed.2019.80.9.530","article-title":"Systemic sclerosis","volume":"80","author":"Hughes","year":"2019","journal-title":"Br. J. Hosp. Med. (Lond)."},{"key":"B38","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s10165-010-0274-x","article-title":"Therapeutic angiogenesis in patients with systemic sclerosis by autologous transplantation of bone-marrow-derived cells","volume":"20","author":"Ishigatsubo","year":"2010","journal-title":"Mod. Rheumatol."},{"key":"B39","first-page":"S19","article-title":"Vascular involvement in systemic sclerosis (SSc)","volume":"22","author":"Kahaleh","year":"2004","journal-title":"Clin. Exp. Rheumatol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/art.1780280607","article-title":"Decreased coronary reserve in primary scleroderma myocardial disease","volume":"28","author":"Kahan","year":"1985","journal-title":"Arthritis Rheum."},{"key":"B41","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.vph.2015.05.015","article-title":"Macro- and microvascular disease in systemic sclerosis","volume":"71","author":"Kavian","year":"2015","journal-title":"Vasc. Pharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41584-021-00678-z","article-title":"Promise and challenge of systemic sclerosis therapies","volume":"17","author":"Kawano","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1165\/rcmb.2020-0581OC","article-title":"A novel regulatory role of activated leukocyte cell-adhesion molecule in the pathogenesis of pulmonary fibrosis","volume":"66","author":"Kim","year":"2022","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/ar2187","article-title":"Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis","volume":"9","author":"Koch","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"B45","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s13287-017-0660-9","article-title":"Exosomes of human placenta-derived mesenchymal stem cells stimulate angiogenesis","volume":"8","author":"Komaki","year":"2017","journal-title":"Stem Cell Res. Ther."},{"key":"B46","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/1756-185X.12522","article-title":"Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells, and increased levels of IL-21 in bleomycin-induced mice may be associated with dermal and pulmonary inflammation and fibrosis","volume":"19","author":"Lei","year":"2016","journal-title":"Int. J. Rheum. Dis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.pcl.2018.04.002","article-title":"Scleroderma in children and adolescents: localized scleroderma and systemic sclerosis","volume":"65","author":"Li","year":"2018","journal-title":"Pediatr. Clin. North Am."},{"key":"B48","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.toxlet.2017.02.016","article-title":"Bone marrow mesenchymal stem cells attenuate silica-induced pulmonary fibrosis via paracrine mechanisms","volume":"270","author":"Li","year":"2017","journal-title":"Toxicol. Lett."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1007\/s10753-018-0820-9","article-title":"Interleukin-37 attenuates bleomycin-induced pulmonary inflammation and fibrosis in mice","volume":"41","author":"Li","year":"2018","journal-title":"Inflammation"},{"key":"B50","doi-asserted-by":"publisher","first-page":"4223","DOI":"10.1186\/s13075-014-0512-2","article-title":"Interleukin-17A promotes functional activation of systemic sclerosis patient-derived dermal vascular smooth muscle cells by extracellular-regulated protein kinases signalling pathway","volume":"16","author":"Liu","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"B51","doi-asserted-by":"publisher","first-page":"594735","DOI":"10.3389\/fimmu.2020.594735","article-title":"The IL-23\/IL-17 pathway in inflammatory skin diseases: from bench to bedside","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"e315","DOI":"10.1016\/j.lpm.2014.03.027","article-title":"Musculoskeletal involvement in systemic sclerosis","volume":"43","author":"Lorand","year":"2014","journal-title":"Presse Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/80533","article-title":"Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells","volume":"6","author":"Lunardi","year":"2000","journal-title":"Nat. Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13287-018-1122-8","article-title":"Transplantation of bone marrow mesenchymal stromal cells attenuates liver fibrosis in mice by regulating macrophage subtypes","volume":"10","author":"Luo","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1093\/rheumatology\/keaa669","article-title":"Imbalance toward TFH 1 cells playing a role in aberrant B cell differentiation in systemic sclerosis","volume":"60","author":"Ly","year":"2021","journal-title":"Rheumatol. Oxf."},{"key":"B56","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1172\/JCI131700","article-title":"Cytotoxic CD4+ T lymphocytes may induce endothelial cell apoptosis in systemic sclerosis","volume":"130","author":"Maehara","year":"2020","journal-title":"J. Clin. Invest."},{"key":"B57","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1136\/annrheumdis-2018-214218","article-title":"Molecular profile and proangiogenic activity of the adipose-derived stromal vascular fraction used as an autologous innovative medicinal product in patients with systemic sclerosis","volume":"78","author":"Magalon","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"B58","doi-asserted-by":"publisher","first-page":"e128060","DOI":"10.1172\/jci.insight.128060","article-title":"Mesenchymal stromal cell exosomes prevent and revert experimental pulmonary fibrosis through modulation of monocyte phenotypes","volume":"4","author":"Mansouri","year":"2019","journal-title":"JCI Insight"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1002\/art.37988","article-title":"Review: evidence that systemic sclerosis is a vascular disease","volume":"65","author":"Matucci-Cerinic","year":"2013","journal-title":"Arthritis Rheum."},{"key":"B60","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s12967-021-02980-6","article-title":"A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine","volume":"19","author":"Moghadasi","year":"2021","journal-title":"J. Transl. Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1164\/rccm.201701-0170OC","article-title":"Mesenchymal stromal cells modulate macrophages in clinically relevant lung injury models by extracellular vesicle mitochondrial transfer","volume":"196","author":"Morrison","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.rdc.2007.12.006","article-title":"Vascular disease in scleroderma: angiogenesis and vascular repair","volume":"34","author":"Mulligan-Kehoe","year":"2008","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"B63","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/rheumatology\/ken407","article-title":"Autologous progenitor cell implantation as a novel therapeutic intervention for ischaemic digits in systemic sclerosis","volume":"48","author":"Nevskaya","year":"2009","journal-title":"Rheumatol. Oxf."},{"key":"B64","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1165\/rcmb.2017-0326OC","article-title":"PD-1\/PD-L1 pathway mediates the alleviation of pulmonary fibrosis by human mesenchymal stem cells in humanized mice","volume":"58","author":"Ni","year":"2018","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B65","volume-title":"Scleroderma","author":"Odonwodo","year":"2023"},{"key":"B66","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12929-018-0429-1","article-title":"Regenerative abilities of mesenchymal stem cells through mitochondrial transfer","volume":"25","author":"Paliwal","year":"2018","journal-title":"J. Biomed. Sci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/resp.13928","article-title":"Anti-fibrotic effects of different sources of MSC in bleomycin-induced lung fibrosis in C57BL6 male mice","volume":"26","author":"Periera-Simon","year":"2021","journal-title":"Respirology"},{"key":"B68","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1172\/JCI116015","article-title":"Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4","volume":"90","author":"Postlethwaite","year":"1992","journal-title":"J. Clin. Invest."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1007\/s11033-019-04588-y","article-title":"Mesenchymal stem cell-based therapy for autoimmune diseases: emerging roles of extracellular vesicles","volume":"46","author":"Rad","year":"2019","journal-title":"Mol. Biol. Rep."},{"key":"B71","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/ndt\/gfp552","article-title":"Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation","volume":"25","author":"Reinders","year":"2010","journal-title":"Nephrol. Dial. Transpl."},{"key":"B72","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1136\/annrheumdis-2018-214382","article-title":"Circulating follicular helper T cells are increased in systemic sclerosis and promote plasmablast differentiation through the IL-21 pathway which can be inhibited by ruxolitinib","volume":"78","author":"Ricard","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"B73","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.semarthrit.2014.05.010","article-title":"Mortality and survival in systemic sclerosis: systematic review and meta-analysis","volume":"44","author":"Rubio-Rivas","year":"2014","journal-title":"Semin. Arthritis Rheum."},{"key":"B74","doi-asserted-by":"publisher","first-page":"e93726","DOI":"10.1371\/journal.pone.0093726","article-title":"Human Wharton's Jelly Mesenchymal Stem Cells plasticity augments scar-free skin wound healing with hair growth","volume":"9","author":"Sabapathy","year":"2014","journal-title":"PLoS One"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1084\/jem.192.11.1553","article-title":"CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function","volume":"192","author":"Schaerli","year":"2000","journal-title":"J. Exp. Med."},{"key":"B76","doi-asserted-by":"publisher","first-page":"103330","DOI":"10.1016\/j.autrev.2023.103330","article-title":"Renal involvement in systemic sclerosis","volume":"22","author":"Scheen","year":"2023","journal-title":"Autoimmun. Rev."},{"key":"B77","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1177\/2397198319870667","article-title":"Pathogenic roles of autoantibodies in systemic sclerosis: current understandings in pathogenesis","volume":"5","author":"Senecal","year":"2020","journal-title":"J. Scleroderma Relat. Disord."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/s0755-4982(06)74924-7","article-title":"Systemic sclerosis: pathophysiology of a multifaceted disease","volume":"35","author":"Servettaz","year":"2006","journal-title":"Presse Med."},{"key":"B79","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.it.2011.11.004","article-title":"How mesenchymal stem cells interact with tissue immune responses","volume":"33","author":"Shi","year":"2012","journal-title":"Trends Immunol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"951535","DOI":"10.3389\/fimmu.2022.951535","article-title":"Pathogenic roles and diagnostic utility of interleukin-18 in autoinflammatory diseases","volume":"13","author":"Shimizu","year":"2022","journal-title":"Front. Immunol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cellimm.2016.12.005","article-title":"Toll-like receptors as a key regulator of mesenchymal stem cell function: an up-to-date review","volume":"315","author":"Shirjang","year":"2017","journal-title":"Cell. Immunol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1177\/0394632017722332","article-title":"Human periodontal ligament stem cells secretome from multiple sclerosis patients suppresses NALP3 inflammasome activation in experimental autoimmune encephalomyelitis","volume":"30","author":"Soundara","year":"2017","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/s1568-9972(03)00004-1","article-title":"New insights into the pathogenesis of systemic sclerosis","volume":"2","author":"Tamby","year":"2003","journal-title":"Autoimmun. Rev."},{"key":"B84","doi-asserted-by":"publisher","first-page":"eaaf5307","DOI":"10.1126\/scitranslmed.aaf5307","article-title":"T follicular helper-like cells contribute to skin fibrosis","volume":"10","author":"Taylor","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/art.37860","article-title":"Interleukin-17A+ cell counts are increased in systemic sclerosis skin and their number is inversely correlated with the extent of skin involvement","volume":"65","author":"Truchetet","year":"2013","journal-title":"Arthritis Rheum."},{"key":"B86","doi-asserted-by":"publisher","first-page":"eabe3037","DOI":"10.1126\/scitranslmed.abe3037","article-title":"Oncostatin M can sensitize sensory neurons in inflammatory pruritus","volume":"13","author":"Tseng","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"B87","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2147\/SCCAA.S135414","article-title":"Stem cells for luminal, fistulizing, and perianal inflammatory bowel disease: a comprehensive updated review of the literature","volume":"11","author":"Turse","year":"2018","journal-title":"Stem Cells Cloning"},{"key":"B88","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11926-015-0555-7","article-title":"Cellular therapies in systemic sclerosis: recent progress","volume":"18","author":"van Rhijn-Brouwer","year":"2016","journal-title":"Curr. Rheumatol. Rep."},{"key":"B89","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fimmu.2020.00220","article-title":"T-cell proapoptotic and antifibrotic activity against autologous skin fibroblasts in vitro is associated with IL-17a Axis upregulation in systemic sclerosis","volume":"11","author":"Vettori","year":"2020","journal-title":"Front. Immunol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1007\/s00296-017-3846-7","article-title":"Causes of death, survival and risk factors of mortality in Thai patients with early systemic sclerosis: inception cohort study","volume":"37","author":"Wangkaew","year":"2017","journal-title":"Rheumatol. Int."},{"key":"B91","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1164\/rccm.201705-0925OC","article-title":"Mesenchymal stromal cell exosomes ameliorate experimental bronchopulmonary dysplasia and restore lung function through macrophage immunomodulation","volume":"197","author":"Willis","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B92","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nrneph.2016.124","article-title":"Scleroderma renal crisis and renal involvement in systemic sclerosis","volume":"12","author":"Woodworth","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"13600","DOI":"10.1111\/jcmm.15266","article-title":"IFN-\u03b3+ IL-17+ Th17 cells regulate fibrosis through secreting IL-21 in systemic scleroderma","volume":"24","author":"Xing","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"B94","doi-asserted-by":"publisher","first-page":"e85032","DOI":"10.1371\/journal.pone.0085032","article-title":"IL-17A induces endothelial inflammation in systemic sclerosis via the ERK signaling pathway","volume":"8","author":"Xing","year":"2013","journal-title":"PLoS One"},{"key":"B95","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13287-017-0535-0","article-title":"Umbilical cord-derived mesenchymal stem cells on scaffolds facilitate collagen degradation via upregulation of MMP-9 in rat uterine scars","volume":"8","author":"Xu","year":"2017","journal-title":"Stem Cell Res. Ther."},{"key":"B96","doi-asserted-by":"publisher","first-page":"988","DOI":"10.12122\/j.issn.1673-4254.2020.07.11","article-title":"Human umbilical cord mesenchymal stem cell-derived exosomes alleviate pulmonary fibrosis in mice by inhibiting epithelial-mesenchymal transition","volume":"40","author":"Yang","year":"","journal-title":"Nan Fang. Yi Ke Da Xue Xue Bao"},{"key":"B97","doi-asserted-by":"publisher","first-page":"639657","DOI":"10.3389\/fcell.2021.639657","article-title":"Therapeutic applications of mesenchymal stem cells in idiopathic pulmonary fibrosis","volume":"9","author":"Yang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3892\/etm.2020.9387","article-title":"Human umbilical cord mesenchymal stem cells ameliorate skin fibrosis development in a mouse model of bleomycin-induced systemic sclerosis","volume":"20","author":"Yang","year":"","journal-title":"Exp. Ther. Med."},{"key":"B99","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s13770-021-00405-5","article-title":"The therapeutic effects of exosomes derived from human umbilical cord mesenchymal stem cells on scleroderma","volume":"19","author":"Yu","year":"2022","journal-title":"Tissue Eng. Regen. Med."},{"key":"B100","doi-asserted-by":"publisher","first-page":"65","DOI":"10.7326\/0003-4819-155-1-201107050-00013","article-title":"Autologous mesenchymal stem cells foster revascularization of ischemic limbs in systemic sclerosis","volume":"155","author":"Yun","year":"2011","journal-title":"Ann. Intern. Med."},{"key":"B101","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13075-017-1373-2","article-title":"Sustained benefit from combined plasmapheresis and allogeneic mesenchymal stem cells transplantation therapy in systemic sclerosis","volume":"19","author":"Zhang","year":"2017","journal-title":"Arthritis Res. Ther."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1263839\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T11:40:34Z","timestamp":1692963634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1263839\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,25]]},"references-count":101,"alternative-id":["10.3389\/fphar.2023.1263839"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1263839","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,25]]},"article-number":"1263839"}}